Guidelines on the management and treatment of glucocorticoid-induced osteoporosis of the Japanese Society for Bone and Mineral Research (2004)

J Bone Miner Metab. 2005;23(2):105-9. doi: 10.1007/s00774-004-0596-x.

Authors

Hajime Nawata¹, Satoshi Soen, Ryoichi Takayanagi, Ikuko Tanaka, Kunio Takaoka, Masao Fukunaga, Toshio Matsumoto, Yasuo Suzuki, Hiroyuki Tanaka, Saeko Fujiwara, Takami Miki, Akira Sagawa, Yoshiki Nishizawa, Yoshiki Seino; Subcommittee to Study Diagnostic Criteria for Glucocorticoid-Induced Osteoporosis

Affiliation

¹ Department of Medicine and Bioregulatory Science, Graduate School of Medical Science, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan. nawata@intmed3.med.kyushu-u.ac.jp

PMID: 15750687
DOI: 10.1007/s00774-004-0596-x

No abstract available

Publication types

Guideline
Practice Guideline

MeSH terms

Adolescent
Adult
Aged
Bone Density / drug effects
Diphosphonates / therapeutic use*
Female
Glucocorticoids / adverse effects*
Humans
Male
Middle Aged
Osteoporosis / chemically induced*
Osteoporosis / drug therapy*

Substances

Diphosphonates
Glucocorticoids